Pharmabiz31m
BioNxt Solutions announces development of sublingual thin-film ODF for Semaglutide
BioNxt Solutions announces development of sublingual thin-film ODF for Semaglutide: Vancouver, BC Tuesday, December 3, 2024, 17:00 Hrs [IST] BioNxt Solutions Inc., a bioscience co ...
Pharmabiz1h
US FDA grants Orphan Drug Designation to AAVantgarde Bio’s AAVB-081 to treat Usher Syndrome Type 1B retinitis pigmentosa
US FDA grants Orphan Drug Designation to AAVantgarde Bio’s AAVB-081 to treat Usher Syndrome Type 1B retinitis pigmentosa: Milan, Italy Tuesday, December 3, 2024, 16:00 Hrs [IST] ...
Pharmabiz2h
Endo introduces US FDA approved Adrenalin ready-to-use premixed bag
Endo introduces US FDA approved Adrenalin ready-to-use premixed bag: Malvern, Pennsylvania Tuesday, December 3, 2024, 15:00 Hrs [IST] Endo, Inc., a diversified specialty pharmaceu ...
Pharmabiz3h
PTC Therapeutics inks global license and collaboration agreement with Novartis for PTC518 Huntington's disease programme
PTC Therapeutics inks global license and collaboration agreement with Novartis for PTC518 Huntington's disease programme: Warren, New Jersey Tuesday, December 3, 2024, 14:00 Hrs [ ...
Pharmabiz4h
HCG and Accenture collaborate on cancer research and care using advanced AI
HCG and Accenture collaborate on cancer research and care using advanced AI: Our Bureau, Bengaluru Tuesday, December 3, 2024, 12:50 Hrs [IST] HealthCare Global Enterprises (HCG) i ...
Pharmabiz4h
Bayer showcases innovations in radiology portfolio at RSNA 2024 meeting
Bayer showcases innovations in radiology portfolio at RSNA 2024 meeting: Berlin Tuesday, December 3, 2024, 13:00 Hrs [IST] Bayer continues to advance its comprehensive radiology p ...
Pharmabiz4h
Gland Pharma receives US FDA approval for generic Xalatan
Our Bureau, Bengaluru Tuesday, December 3, 2024, 12:40 Hrs [IST] Gland Pharma, a generic injectable–focused pharmaceut ...
Pharmabiz4h
MSMEs ready to embrace revised Schedule M to ensure drug quality: Dr H G Koshia
“Indian Pharma MSMEs are now more proactive in implementing the Revised Schedule M guidelines. They are gearing up to establish a robust Pharmaceutical Quality System (PQS), integrate Quality Risk ...
Pharmabiz7h
Everest Medicines announces acceptance of Velsipity NDA in Hong Kong to treat moderately to severely active ulcerative colitis
Everest Medicines announces acceptance of Velsipity NDA in Hong Kong to treat moderately to severely active ulcerative colitis: Shanghai, China Tuesday, December 3, 2024, 10:00 Hr ...
Pharmabiz5h
Neo Medical’s spine care platform fully approved under EU Medical Device Regulation directive
Neo Medical’s spine care platform fully approved under EU Medical Device Regulation directive: Lausanne, Switzerland Tuesday, December 3, 2024, 12:00 Hrs [IST] Neo Medical SA (N ...
Pharmabiz6h
Renalys Pharma’s sparsentan receives Japanese Orphan Drug Designation for primary IgA nephropathy
Renalys Pharma’s sparsentan receives Japanese Orphan Drug Designation for primary IgA nephropathy: Tokyo, Japan Tuesday, December 3, 2024, 11:00 Hrs [IST] Renalys Pharma, Inc., ...
Pharmabiz9h
AIPPSPA to discuss NPC Bill 2023 & Pharmacy Act 1948 at its meeting on Dec 7 & 8 at Thiruvananthapuram
AIPPSPA to discuss NPC Bill 2023 & Pharmacy Act 1948 at its meeting on Dec 7 & 8 at Thiruvananthapuram: Peethaambaran Kunnathoor, Chennai Tuesday, December 3, 2024, 08:00 Hrs [IST ...